Lnc-PICSAR contributes to cisplatin resistance by miR-485-5p/REV3L axis in cutaneous squamous cell carcinoma

Dan Wang1, Xiaoqiang Zhou2, Jing Yin3

  • 1Plastic Surgery Center, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214000, China.

Open Life Sciences
|April 5, 2021
PubMed
Abstract

Insights

Long noncoding RNA PICSAR promotes cisplatin resistance in cutaneous squamous cell carcinoma by regulating the miR-485-5p/REV3L pathway. Exosomal PICSAR may also contribute to drug resistance in CSCC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Dysregulation of long noncoding RNAs (lncRNAs) is implicated in cancer drug resistance.
  • Cutaneous squamous cell carcinoma (CSCC) exhibits resistance to cisplatin (DDP), a common chemotherapeutic agent.

Purpose of the Study:

  • To investigate the role of lncRNA PICSAR in DDP resistance in CSCC.
  • To elucidate the molecular mechanism underlying PICSAR's function in DDP-resistant CSCC.

Main Methods:

  • Quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot assays.
  • Cell counting kit-8 (CCK-8), transwell, and dual-luciferase reporter assays.
  • Murine xenograft models and exosome analysis (TEM, NTA).

Main Results:

  • Lnc-PICSAR expression was elevated in DDP-resistant CSCC cells and patient-derived exosomes.
  • Silencing lnc-PICSAR reduced cell viability, DDP resistance, migration, and invasion.
  • Lnc-PICSAR sponges miR-485-5p, leading to increased REV3L expression, which promotes CSCC progression and DDP resistance.
  • Lnc-PICSAR knockdown inhibited DDP resistance in vivo.

Conclusions:

  • Lnc-PICSAR enhances DDP resistance in CSCC through the miR-485-5p/REV3L axis.
  • Exosome-mediated lnc-PICSAR may play a role in CSCC drug resistance, suggesting potential diagnostic or therapeutic targets.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K